Infectious Disease - Antimicrobials News & Articles

1 Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child transmission The Journal of Infectious Diseases, May 24, 2013    Clinical Article

2 Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections Clinical Infectious Diseases, May 24, 2013    Clinical Article

3 Is azole resistance in aspergillus fumigatus a problem in spain? Antimicrobial Agents and Chemotherapy, May 24, 2013    Clinical Article

4 Activities of first-choice antimicrobials against gamma interferon-treated chlamydia trachomatis differ in hypoxia Antimicrobial Agents and Chemotherapy, May 24, 2013    Review Article

5 Heteroresistance to fosfomycin is predominant in streptococcus pneumoniae and depends on the mura1 gene Antimicrobial Agents and Chemotherapy, May 24, 2013    Clinical Article

6 Safety profile comparing azathioprine and mycophenolate in kidney transplant recipients receiving tacrolimus and corticosteroids Transplant Infectious Disease, May 24, 2013    Clinical Article

7 Staphylococcus aureus nasal carriage among injecting and non-injecting drug users and antimicrobial susceptibility Full Text American Journal of Infectious Diseases, May 24, 2013    Clinical Article

8 10 x 20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America Clinical Infectious Diseases, May 23, 2013    Clinical Article

9 Differential penetration of raltegravir throughout gastrointestinal tissue: implications for eradication and cure AIDS, May 23, 2013    Clinical Article

10 Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: A randomized controlled trial Clinical Infectious Diseases, May 23, 2013    Clinical Article

11 Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations Clinical Infectious Diseases, May 23, 2013    Clinical Article

12 The use of steroids to prevent cutaneous reactions to benznidazole in patients with Chagas disease Pathogens and Global Health, May 23, 2013    Clinical Article

13 Use of rifamycin drugs and development of infection by rifamycin-resistant strains of clostridium difficile Antimicrobial Agents and Chemotherapy, May 23, 2013    Clinical Article

14 Rationale, design and organization of the delayed antibiotic prescription (DAP) trial: a randomized controlled trial of the efficacy and safety of delayed antibiotic prescribing strategies in the non-complicated acute respiratory tract infections in general practice Full Text BMC Family Practice, May 23, 2013    Clinical Article

15 Comparative activities of telavancin combined with nafcillin, imipenem, and gentamicin against staphylococcus aureus Antimicrobial Agents and Chemotherapy, May 23, 2013    Clinical Article

16 Identification and Characterization of a Novel HIV-1 Nucleotide-Competing Reverse Transcriptase Inhibitor Series Antimicrobial Agents and Chemotherapy, May 23, 2013    Clinical Article

17 Safety and tolerability of luliconazole solution 10-percent in patients with moderate to severe distal subungual onychomycosis Antimicrobial Agents and Chemotherapy, May 23, 2013    Clinical Article

18 Efficacy and safety of liposomal clarithromycin and its effect on pseudomonas aeruginosa virulence factors Antimicrobial Agents and Chemotherapy, May 23, 2013    Clinical Article

19 A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against staphylococcus aureus biofilms Antimicrobial Agents and Chemotherapy, May 23, 2013    Clinical Article

20 Human organic cation transporters 1 (slc22a1), 2 (slc22a2), and 3 (slc22a3) as disposition pathways for fluoroquinolone antimicrobials Antimicrobial Agents and Chemotherapy, May 23, 2013    Clinical Article

1 Infective Endocarditis New England Journal of Medicine, April 12, 2013

2 Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin MIC>1 mg/L: a matched cohort study Clinical Infectious Diseases, March 15, 2013

3 Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study Clinical Infectious Diseases, April 1, 2013

4 Clostridium Difficile Colitis: Review of the Therapeutic Approach American Journal of Therapeutics, April 8, 2013

5 Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections Cochrane Reviews, March 29, 2013    Review Article

6 Cobicistat Versus Ritonavir as a Pharmacoenhancer of Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive HIV Type 1-Infected Patients: Week 48 Results The Journal of Infectious Diseases, April 22, 2013

7 Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials European Journal of Clinical Microbiology & Infectious Diseases, April 10, 2013    Evidence Based Medicine

8 Clustering of Antimicrobial Resistance Outbreaks Across Bacterial Species in the Intensive Care Unit Clinical Infectious Diseases, April 18, 2013

9 Clinical Trial: Comparative Effectiveness of Cephalexin Plus Trimethoprim-Sulfamethoxazole Versus Cephalexin Alone for Treatment of Uncomplicated Cellulitis: A Randomized Controlled Trial Clinical Infectious Diseases, April 3, 2013

10 Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach The Lancet Infectious Diseases, March 20, 2013

11 Adverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis AIDS, April 23, 2013    Evidence Based Medicine    Review Article

12 Outcomes of Appropriate Empiric Combination versus Monotherapy for Pseudomonas aeruginosa Bacteremia Antimicrobial Agents and Chemotherapy, March 6, 2013

13 A Randomized Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate for Initial Treatment of HIV-1 Infection: Analysis of Week 96 Results Journal of Acquired Immune Deficiency Syndromes, April 17, 2013

14 Cobicistat: A New Boost for the Treatment of Human Immunodeficiency Virus Infection Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, March 13, 2013

15 Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients: Final 5-Year Results From STARTMRK Journal of Acquired Immune Deficiency Syndromes, April 16, 2013

16 Linezolid versus vancomycin for meticillin-resistant Staphylococcus aureus infection: a meta-analysis of randomised controlled trials International Journal of Antimicrobial Agents, April 23, 2013    Evidence Based Medicine

17 De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock Cochrane Reviews, April 11, 2013    Review Article

18 Ampicillin Plus Ceftriaxone Is as Effective as Ampicillin Plus Gentamicin for Treating Enterococcus faecalis Infective Endocarditis Clinical Infectious Diseases, April 10, 2013

19 What is the Best Antimicrobial Treatment for Severe Community-Acquired Pneumonia (Including the Role of Steroids and Statins and Other Immunomodulatory Agents) Infectious Disease Clinics of North America, February 18, 2013

20 New antifungal antibiotics Current Opinion in Infectious Diseases, February 27, 2013